![](https://monteverdelaw.com/wp-content/uploads/case-logo/gtx-inc.png)
We are investigating GTx, Inc. (NasdaqCM: GTXI) (“GTx”) regarding the merger agreement between GTx and Oncternal Therapeutics, Inc., where GTx stockholders will own approximately 25% of the combined company.
We are investigating GTx, Inc. (NasdaqCM: GTXI) (“GTx”) regarding the merger agreement between GTx and Oncternal Therapeutics, Inc., where GTx stockholders will own approximately 25% of the combined company.